Compare RVSB & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | RVSB | BHST |
|---|---|---|
| Founded | 1923 | 2007 |
| Country | United States | Canada |
| Employees | N/A | 87 |
| Industry | Savings Institutions | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.9M | 104.2M |
| IPO Year | 1997 | N/A |
| Metric | RVSB | BHST |
|---|---|---|
| Price | $5.07 | $4.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $7.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 39.0K | 16.5K |
| Earning Date | 04-28-2026 | 03-31-2026 |
| Dividend Yield | ★ 1.58% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.67 | $116.40 |
| Revenue Next Year | $9.82 | $55.91 |
| P/E Ratio | $28.11 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.74 | $4.10 |
| 52 Week High | $6.59 | $12.80 |
| Indicator | RVSB | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 33.12 | 49.08 |
| Support Level | $5.03 | $4.19 |
| Resistance Level | $5.19 | $5.02 |
| Average True Range (ATR) | 0.13 | 0.25 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 10.20 | 51.35 |
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.